Event: DIA Europe 2025
Date: March 18-20, 2025
Location: Congress Center Basel, Switzerland
DIA Europe 2025 will focus on sustainability, innovation and collaboration – three key pillars for shaping the future of healthcare. From the environmental impact of pharmaceuticals and of the drug development lifecycle to sustainable partnerships and sustainable healthcare systems, DIA Europe 2025 will be the prime opportunity to discuss how collaboration and innovation can support sustainability in healthcare and each stakeholder’s role in making it happen. AlphaLife Sciences is excited to participate and share our insights at the event. We look forward to engaging with you in person!
Booth Number: B2
Presentation from AlphaLife Sciences:
Date: March 19
Time: 11:50-12:15
Speaker: Sharon Chen, Founder and CEO, AlphaLife Sciences
Session type: Innovation Hub
Topic: GenAI in Action: Demo and Real-World Case Studies Transforming Medical Writing in Global Pharma
Abstract:
This session will present an off-the-shelf GenAI-powered Medical and Regulatory Authoring platform, proven in global pharmaceutical deployments. Real-world case studies highlight how it reduces first-draft CSR and protocol preparation to minutes, achieving overall time savings of 50%.
Key points to explain and demo include:
Integrated Authoring Solution:
Demonstrate a Word plugin designed to seamlessly integrate with existing workflows and upstream/downstream systems (e.g., Veeva RIM) to automate document assembly.
Cross-Document Content Reuse & Standardization:
Demonstrate a GenAI framework for reusing and standardizing content across multiple document types, enabling enterprise-wide, scalable authoring.
GenAI-Driven Quality Control:
Explanation of an automated quality control process harnessing GenAI to ensure accuracy, consistency, and regulatory compliance.
Change Management Strategy:
Practical insights and lessons learned from enterprise deployments, including approaches and best practices for effective GenAI adoption, along with measurable outcomes and cost-effective strategies.
Who Should Attend:
Medical writers, regulatory executives, and professionals in digital innovation, R&D, IT, and clinical development who aim to streamline authoring processes. Attendees will gain actionable strategies, deeper insight into real-world GenAI applications, and proven examples of measurable benefits.
To request a meeting, fill out the form provided and a representative will be in contact soon to schedule.
